MMED
MiniMed Group, Inc.
$14.23
+1.21%
$4.0B
No data for this timeframe.
Vol
Market Cap$4.0B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (87%)
Inst. Holders7 funds
Inst. Value$61.2M
Inst. Activity6 buys / 1 sells
SEC Reports6
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0002062583·Prev Close $14.06
Recent Activity
Jun 3, 2026
SEC
MiniMed reported Q4 FY2026 net sales of $837M (+15.6% YoY as reported, +8.7% organic), surpassing $3B in annual revenue
8-K — Impact 6/10
May 18, 2026
SEC
MiniMed disclosed the resignation of director Brett Wall, effective July 3, 2026, due to his departure from parent Medtr
8-K — Impact 2/10
Apr 27, 2026
SEC
MiniMed Group, Inc. disclosed that its parent company, Medtronic plc, experienced a cybersecurity incident involving una
8-K — Impact 5/10
Mar 25, 2026
Insider
Dallara Que sold 4,809 shares
Chief Executive Officer @ $16.31 ($78.4K)
Mar 11, 2026
Insider
Gyurci John sold 15,322 shares
See Remarks @ $0.00 ($0.00)
Mar 11, 2026
Insider
Chandrasena Gillian sold 19,852 shares
See Remarks @ $0.00 ($0.00)
Inst.
VANGUARD GROUP INC — ADD
2,591,901 shares ($34.7M)
Inst.
CHARLES SCHWAB INVESTMENT MANAGEMENT — ADD
807,249 shares ($10.8M)
Price Targets
$20.91
+46.9% upside
Strong Buy
Current $14.23
Low $16.00
Median $20.00
High $25.00
11 analysts
$16.00
$25.00
Analyst Ratings
5Strong Buy
8Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 4, 2026 | Wells Fargo | MAINTAIN | Overweight → Overweight |
| May 18, 2026 | B of A Securities | MAINTAIN | Buy → Buy |
| May 12, 2026 | Benchmark | INITIATE | Buy |
| Apr 1, 2026 | Barclays | INITIATE | Overweight |
| Mar 31, 2026 | William Blair | INITIATE | Outperform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.12 ▼ -8.6% | $0.07 — $0.20 | 7 | |
| Next Q | $0.16 ▲ +4.8% | $0.14 — $0.20 | 7 | |
| Current FY | $0.66 ▼ -1.7% | $0.57 — $0.87 | 7 | |
| Next FY | $0.65 ▼ -21.6% | $0.10 — $0.82 | -2% YoY | 8 |
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $34.7M | ADD |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $10.8M | ADD |
| TWO SIGMA INVESTMENTS, LP | $5.7M | ADD |
| MORGAN STANLEY | $4.9M | TRIM |
| FMR LLC | $2.2M | DOUBLED |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 25, 2026 | Dallara Que | F | $78.4K |
| Mar 11, 2026 | Gyurci John | A | $0.00 |
| Mar 11, 2026 | Chandrasena Gillian | A | $0.00 |
| Mar 11, 2026 | Wills Courtney | A | $0.00 |
| Mar 11, 2026 | Dallara Que | A | $0.00 |
7 institutional holders with $61.2M total value (4,570,629 shares) as of 2025-Q4. Top holders: VANGUARD, CHARLES, TWO. Net buying activity: 6 institutions added/increased vs 1 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 2,591,901 | $34.7M | 56.7% | ADD +28.8% |
| 2 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 807,249 | $10.8M | 17.7% | ADD +27.4% |
| 3 | TWO SIGMA INVESTMENTS, LP | 425,207 | $5.7M | 9.3% | ADD +43.4% |
| 4 | MORGAN STANLEY | 366,695 | $4.9M | 8.0% | TRIM -26.0% |
| 5 | FMR LLC | 162,053 | $2.2M | 3.5% | DOUBLED +941.6% |
| 6 | BANK OF AMERICA CORP /DE/ | 110,467 | $1.5M | 2.4% | ADD +31.5% |
| 7 | WELLS FARGO & COMPANY/MN | 107,057 | $1.4M | 2.3% | ADD +89.5% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | ADD | 2,012,874 | 2,591,901 | +28.8% | $34.7M | 2025-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 633,702 | 807,249 | +27.4% | $10.8M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | ADD | 296,443 | 425,207 | +43.4% | $5.7M | 2025-Q4 |
| MORGAN STANLEY | TRIM | 495,618 | 366,695 | -26.0% | $4.9M | 2025-Q4 |
| FMR LLC | DOUBLED | 15,558 | 162,053 | +941.6% | $2.2M | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 84,011 | 110,467 | +31.5% | $1.5M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 56,495 | 107,057 | +89.5% | $1.4M | 2025-Q4 |
| MORGAN STANLEY | TRIM | 688,531 | 495,618 | -28.0% | $5.8M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 56,478 | 296,443 | +424.9% | $3.5M | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 119,214 | 84,011 | -29.5% | $990.5K | 2025-Q3 |
| UBS Group AG | DOUBLED | 108,026 | 514,445 | +376.2% | $3.3M | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | ADD | 88,222 | 119,214 | +35.1% | $773.7K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | ADD | 37,416 | 47,717 | +27.5% | $309.7K | 2025-Q2 |
| CITADEL ADVISORS LLC | ADD | 447,060 | 751,890 | +68.2% | $4.4M | 2025-Q1 |
| MORGAN STANLEY | ADD | 496,652 | 659,892 | +32.9% | $3.9M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 180,293 | 59,222 | -67.2% | $346.4K | 2025-Q1 |
| FMR LLC | TRIM | 24,909 | 14,412 | -42.1% | $84.3K | 2025-Q1 |
| MORGAN STANLEY | ADD | 355,619 | 496,652 | +39.7% | $3.5M | 2024-Q4 |
| CITADEL ADVISORS LLC | ADD | 283,943 | 447,060 | +57.4% | $3.1M | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 24,705 | 39,974 | +61.8% | $278.2K | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 602,544 | — | $3.4M | 2024-Q3 |
| MORGAN STANLEY | DOUBLED | 157,981 | 355,619 | +125.1% | $2.0M | 2024-Q3 |
10 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Dallara Que | Chief Executive Officer | F | 4,809 | $16.31 | $78.4K |
| Mar 11, 2026 | Gyurci John | See Remarks | A | 15,322 | $0.00 | $0.00 |
| Mar 11, 2026 | Chandrasena Gillian | See Remarks | A | 19,852 | $0.00 | $0.00 |
| Mar 11, 2026 | Wills Courtney Nelson | See Remarks | A | 18,082 | $0.00 | $0.00 |
| Mar 11, 2026 | Dallara Que | Chief Executive Officer | A | 281,937 | $0.00 | $0.00 |
| Mar 11, 2026 | Spooner Chad | EVP, Chief Financial Officer | A | 70,896 | $0.00 | $0.00 |
| Mar 11, 2026 | Dianaty Ali | See Remarks | A | 11,054 | $0.00 | $0.00 |
| Mar 9, 2026 | EISENBERG GLENN A | Director | A | 13,889 | $0.00 | $0.00 |
| Mar 9, 2026 | Spooner Chad | EVP, Chief Financial Officer | A | 84,176 | $0.00 | $0.00 |
| Mar 9, 2026 | Spooner Chad | EVP, Chief Financial Officer | A | 27,778 | $0.00 | $0.00 |
| Mar 9, 2026 | Dallara Que | Chief Executive Officer | A | 252,526 | $0.00 | $0.00 |
| Mar 9, 2026 | Dallara Que | Chief Executive Officer | A | 83,334 | $0.00 | $0.00 |
| Mar 9, 2026 | Dianaty Ali | See Remarks | A | 126,263 | $0.00 | $0.00 |
| Mar 9, 2026 | Dianaty Ali | See Remarks | A | 13,889 | $0.00 | $0.00 |
| Mar 9, 2026 | GROSSMAN D KEITH | Director | A | 13,889 | $0.00 | $0.00 |
| Mar 9, 2026 | Chandrasena Gillian | See Remarks | A | 63,132 | $0.00 | $0.00 |
| Mar 9, 2026 | Chandrasena Gillian | See Remarks | A | 6,945 | $0.00 | $0.00 |
| Mar 9, 2026 | Gyurci John | See Remarks | A | 25,253 | $0.00 | $0.00 |
| Mar 9, 2026 | Gyurci John | See Remarks | A | 2,778 | $0.00 | $0.00 |
| Mar 9, 2026 | Wills Courtney Nelson | See Remarks | A | 63,132 | $0.00 | $0.00 |
| Mar 9, 2026 | Wills Courtney Nelson | See Remarks | A | 6,945 | $0.00 | $0.00 |
| Mar 9, 2026 | Wicks Timothy A | Director | A | 13,889 | $0.00 | $0.00 |
| Mar 9, 2026 | Lofton Kevin E | Director | A | 27,778 | $0.00 | $0.00 |
6 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 2 mixed, 4 neutral. Avg impact: 5.2/10.
MIXED
8-K
6/10
MiniMed reported Q4 FY2026 net sales of $837M (+15.6% YoY as reported, +8.7% organic), surpassing $3
Jun 3, 2026
NEUTRAL
8-K
2/10
MiniMed disclosed the resignation of director Brett Wall, effective July 3, 2026, due to his departu
May 18, 2026
NEUTRAL
8-K
5/10
MiniMed Group, Inc. disclosed that its parent company, Medtronic plc, experienced a cybersecurity in
Apr 27, 2026
NEUTRAL
424B4
5/10
MiniMed Group, Inc. is conducting an initial public offering of 28 million shares at $20.00 per shar
Mar 6, 2026
NEUTRAL
EFFECT
6/10
MiniMed Group, Inc. has had an S-1 registration statement declared effective by the SEC, indicating
Mar 6, 2026
MIXED
S-1/A
7/10
MiniMed Group, Inc. is a global medical technology company spun off from Medtronic, focused on diabe
Feb 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (87% buy). Based on 15 analysts: 5 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$20.91 mean target
+46.9% upside
Strong Buy (1.25)
$16.00 Low
$25.00 High
| Metric | Value |
|---|---|
| Current Price | $14.23 |
| Target Low | $16.00 |
| Target Mean | $20.91 |
| Target Median | $20.00 |
| Target High | $25.00 |
| # Analysts | 11 |
| Recommendation | Strong Buy (1.25) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-07-31 |
$0.12 | $0.07 | $0.20 | — | -8.6% | 0↑ 1↓ | $0.8B | — | 7 |
| Next Q 2026-10-31 |
$0.16 | $0.14 | $0.20 | — | +4.8% | — | $0.8B | — | 7 |
| Current FY 2027-04-30 |
$0.66 | $0.57 | $0.87 | — | -1.7% | — | $3.4B | 15.7% | 7 |
| Next FY 2028-04-30 |
$0.65 | $0.10 | $0.82 | -1.6% | -21.6% | — | $3.7B | 7.9% | 8 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.121 | |
| 7d ago | $0.132 | -0.010 |
| 30d ago | $0.133 | -0.011 |
| 60d ago | $0.124 | -0.003 |
| 90d ago | $0.000 | +0.121 |
11 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 11 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 4, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| May 18, 2026 | B of A Securities | MAINTAIN | Buy | Buy |
| May 12, 2026 | Benchmark | INITIATE | — | Buy |
| Apr 1, 2026 | Barclays | INITIATE | — | Overweight |
| Mar 31, 2026 | William Blair | INITIATE | — | Outperform |
| Mar 31, 2026 | Citigroup | INITIATE | — | Buy |
| Mar 31, 2026 | Piper Sandler | INITIATE | — | Neutral |
| Mar 31, 2026 | Mizuho | INITIATE | — | Outperform |
| Mar 31, 2026 | Wells Fargo | INITIATE | — | Overweight |
| Mar 31, 2026 | Morgan Stanley | INITIATE | — | Overweight |
| Mar 31, 2026 | Evercore ISI Group | INITIATE | — | Outperform |
| Mar 31, 2026 | B of A Securities | INITIATE | — | Buy |
| Mar 31, 2026 | BTIG | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 5 | 8 | 2 | 0 | 0 | 87% | |
| May 1, 2026 | 5 | 7 | 2 | 0 | 0 | 86% | |
| Apr 1, 2026 | 4 | 7 | 2 | 0 | 0 | 85% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 3, 2026
earnings_calendar
MMED Q4 2025 Earnings Scheduled — 2026-06-03
Apr 28, 2026
other
MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System
Latest authorization expands MiniMed CGM portfolio in Canada <pre>Latest authorization expands MiniMed CGM portfolio in Canada</pre>
Apr 15, 2026
short_interest
FTD: MMED — 53,759 shares ($0.8M) failed to deliver
Settlement: 20260415, Price: $15.21, FTD Value: $817,674.39, MINIMED GROUP INC COM
Mar 31, 2026
short_volume
Short Volume: MMED — 66.0% short (0.3M / 0.5M)
Short: 343,767 | Exempt: 211 | TRF Vol: 521,160 | Short Ratio: 66.0% | Off-exchange volume (dark pool + OTC)
Mar 23, 2026
short_interest
FTD: MMED — 36,334 shares ($0.6M) failed to deliver
Settlement: 20260323, Price: $16.57, FTD Value: $602,054.38, MINIMED GROUP INC COM
Mar 13, 2026
short_interest
FTD: MMED — 42,191 shares ($0.7M) failed to deliver
Settlement: 20260313, Price: $16.53, FTD Value: $697,417.23, MINIMED GROUP INC COM
Mar 11, 2026
short_interest
FTD: MMED — 33,431 shares ($0.6M) failed to deliver
Settlement: 20260311, Price: $18.33, FTD Value: $612,790.23, MINIMED GROUP INC COM
Mar 10, 2026
short_interest
FTD: MMED — 1,081,727 shares ($19.5M) failed to deliver
Settlement: 20260310, Price: $18.00, FTD Value: $19,471,086, MINIMED GROUP INC COM
Mar 9, 2026
short_interest
FTD: MMED — 1,757,070 shares ($32.5M) failed to deliver
Settlement: 20260309, Price: $18.49, FTD Value: $32,488,224.3, MINIMED GROUP INC COM